Latest trends in fungal epidemiology inform treatment choices and stewardship initiatives

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

(2012) M. Cuenca-Estrella et al.   CLINICAL MICROBIOLOGY AND INFECTION

Changes in the intestinal microbiota from adulthood through to old age

(2012) P.W. O'Toole   CLINICAL MICROBIOLOGY AND INFECTION

Population Pharmacokinetics of Voriconazole in Adults

(2011) William W. Hope   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis

(2011) P. Campoli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

(2011) David I. Marks et al.   BRITISH JOURNAL OF HAEMATOLOGY

Emergence of five kinds of aminoglycoside-modifying enzyme genes simultaneously in a strain of multidrugresistant Escherichia coli in China

(2011) Z. Wang-Sheng et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colistin pharmacokinetics: the fog is lifting

(2011) W. Couet et al.   CLINICAL MICROBIOLOGY AND INFECTION

Intracellular Concentrations of Posaconazole in Different Compartments of Peripheral Blood

(2010) F. Farowski et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

(2010) J. R. Wingard et al.   BLOOD

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands

(2010) C. H. W. Klaassen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY